For instance, in the United Kingdom, the latest Prostate Cancer Risk Management Programme recommends that general practitioners refer patients to urologists if a well-informed patient aged ≥50 years has a PSA level >3 ng/mL [65]. This evidence concerns the gene KLK3 and prostate carcinoma.